Pharmafile Logo

VJOncology

- PMLiVE

Pharma could make more of its real world evidence

As the ‘cost versus value’ argument rears its head once again a new award could help pharma reaffirm the value of its medicines

- PMLiVE

Change and what’s new

Is anything really that different?

- PMLiVE

Gregory Gallo joins Treato as chief commercial officer

Brings experience from Quest Diagnostics and Johnson & Johnson

EU flag

Sandoz files for approval of Neulasta biosimilar in Europe

Amgen facing increasing competition in global biosimilar market

- PMLiVE

People not positions

The race is on to find - and nurture - the very best talent

- PMLiVE

Mylan agrees to buy Sweden’s Meda for $7.2bn

Deal is set to boost its over-the-counter medicines portfolio 

- PMLiVE

It’s time to get with the real world

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

Lucid Group Communications Limited

- PMLiVE

Alan Kidd moves from GSK to Chase

Takes up role as business development manager

- PMLiVE

woolley pau gyro promotes David Gilchrist and Gareth Williams

They take on the roles of creative director and client services director

- PMLiVE

Lantus sales decline as competition heats up at Sanofi

Brand affected by biosimilars, growth of other new drugs and pricing pressure

- PMLiVE

FDA panel recommends first biosimilar antibody for approval

Pfizer to sell Celltrion's infliximab in the US pending FDA approval

- PMLiVE

UK moves to accelerate digital health uptake

Aims to make London the global capital of digital health technologies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links